Ticker: ANIP

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) has recently published its quarterly earnings report for the period ending June 30, 2025. This report highlights substantial growth in revenues driven largely by acquisitions and product launches, particularly in the Rare Disease segment. Key Financial Hig...